Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

80%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(2)

Detailed Status

Completed3

Withdrawn1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (20.0%)

N/A4 (80.0%)

Trials by Status

withdrawn120%

completed360%

terminated120%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Molecular, Histologic, and Clinical Analysis of Negative Pressure Wound Therapy (NPWT) for Split-thickness Skin Graft (STSG) Donor Sites

NCT02712164

Clinical Trials (5)

Showing 5 of 5 trials

NCT04307355Not Applicable

Continuous Diffusion of Oxygen Treatment for Incision Wounds

Completed

NCT01393795Phase 2

Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients

Completed

NCT05449600Not Applicable

Thermotape High-adhesion Medical Tape Comparison Study

Completed

NCT01002638Not Applicable

The Occlusive Dressing

Terminated

NCT02712164Not Applicable

Molecular, Histologic, and Clinical Analysis of Negative Pressure Wound Therapy (NPWT) for Split-thickness Skin Graft (STSG) Donor Sites

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5